Editorial Article
Ready-to-use iPSC-derived cells transform CRISPR-based functional genomics
Discover how bit.bio's CRISPR-Ready ioCells eliminate months of cell line development
News & Articles
25
Selected Filters:
Product News
CRISPR-Ready ioGlutamatergic Neurons
Product News
bit.bio launches two new human cell disease models to advance discovery and development of treatments for Duchenne muscular dystrophy (DMD)
Models will be used to investigate, screen for and develop therapies for the restoration of dystrophin, the protein that is missing in DMD patients
Industry News
bit.bio launches Huntington’s disease human cell model
First neurodegenerative disease model launched from bit.bio's new ioDisease Model portfolio.
Product News
bit.bio launches first supply of consistent, scalable, human muscle cells
Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development